Inflammation Predicts Cancer Death
A higher white blood cell (WBC) count, a marker of inflammation, is associated with a greater risk of dying from cancer.
In a population of 3,189 participants in the Blue Mountains Eye Study, by the end of the study, there were 212 cancer deaths. Men and women whose white blood count was in the top 25 percent of the study population with greater than 7,400 cells per microliter had a 73 percent higher risk of dying of cancer than those whose white blood cells were in the lowest 25 percent at 5,300 cells or less.
The authors conclude, "Our findings suggest that local inflammatory processes that have long been known to be associated with tumor progression may be reflected in the systemic inflammatory marker of higher WBC count."
Further study details here.
In a population of 3,189 participants in the Blue Mountains Eye Study, by the end of the study, there were 212 cancer deaths. Men and women whose white blood count was in the top 25 percent of the study population with greater than 7,400 cells per microliter had a 73 percent higher risk of dying of cancer than those whose white blood cells were in the lowest 25 percent at 5,300 cells or less.
The authors conclude, "Our findings suggest that local inflammatory processes that have long been known to be associated with tumor progression may be reflected in the systemic inflammatory marker of higher WBC count."
Further study details here.
0 Comments:
Post a Comment
<< Home